
#102 The End of the Amyloid Era with Isaac Stoner: Treating Alzheimer's as a Disease of the Immune System
Isaac Stoner, CEO of MindImmune Therapeutics, a drug discovery company pioneering a new class of medicines for Alzheimer's disease and other neurodegenerative conditions. Isaac has built his career moving between the fou




























